Friday, 21 March 2025
  
Login

Australia's most trusted
source of pharma news

Friday, 21 March 2025
News

Back on board after LinkedIn fiasco

Posted 19 March 2025 PM

After two years in the cold following a dramatic suspension from the UK industry body for serious Code breaches, Novo Nordisk has been welcomed back to the Association of the British Pharmaceutical Industry (ABPI).

The company's return to full membership this week follows extensive audits of its compliance procedures and governance by the ABPI's investigative arm the Prescription Medicines Code of Practice Authority.

To see the whole article, please login

Popular

Aussie pharma Mum on having it all
Why young hot shots are quitting
Back on board after LinkedIn fiasco
Butler brands PBS 'non-negotiable'
Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (2)

Sales & Customer Relations (31)

Clinical & Medical, R&D (12)

Regulatory, Pharmacovigilance & QA (1)

Other (18)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.


Subscribe
 
© 2003 - 2025 Lush Media | Privacy Statement | Subscribe to Pharma in Focus
home